We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$789M
AUM Growth
+$21.4M
Cap. Flow
+$6.25M
Cap. Flow %
0.79%
Top 10 Hldgs %
74.12%
Holding
30
New
4
Increased
6
Reduced
13
Closed
6

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$92.5M
2
HRB icon
H&R Block
HRB
+$43.8M
3
ETFC
E*Trade Financial Corporation
ETFC
+$37.3M
4
MOS icon
The Mosaic Company
MOS
+$13.7M
5
NRF
NorthStar Realty Finance Corp.
NRF
+$8.9M

Top Sells

Rank Stock Value
1
QVCGA
QVC Group Inc Series A
QVCGA
+$31.9M
2
VRNT
Verint Systems
VRNT
+$22.2M
3
AH
Accretive Health
AH
+$19.1M
4
LORL
Loral Space and Communications, Inc.
LORL
+$18M
5
ATI icon
ATI
ATI
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.51%
2 Consumer Discretionary 18.62%
3 Financials 16.24%
4 Industrials 9.81%
5 Materials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENT
26
DELISTED
Global Eagle Entertainment Inc.
ENT
– –
-5,476
Closed -$1.28M
CBK
27
DELISTED
Christopher & Banks Corporation
CBK
– –
-131,292
Closed -$947K
RSH
28
DELISTED
RADIOSHACK CORP
RSH
– –
-1,750,000
Closed -$5.97M
AH
29
DELISTED
Accretive Health
AH
– –
-2,098,700
Closed -$19.1M
GCVRZ
30
DELISTED
Sanofi Contingent Value Rights
GCVRZ
– –
-4,933,961
Closed -$9.97M
1
2

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM

North Run Capital's Q4 2013 Portfolio in Review

As of Q4 2013, North Run Capital held 30 positions worth $789M, up 2.8% from $768M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

North Run Capital's Q4 2013 filing shows 4 new, 6 increased, 13 reduced and 6 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,350,000 shares worth $94.2M. The largest sale was QVC Group Inc Series A, an estimated $31.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

  • North Run Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 2,350,000 shares worth $94.2M.
  • North Run Capital added most to The Mosaic Company in Q4 2013, an estimated $13.7M increase.
  • North Run Capital's biggest Q4 2013 reduction was QVC Group Inc Series A, cutting an estimated $31.9M.
  • North Run Capital fully exited Verint Systems in Q4 2013, selling an estimated $22.2M.
  • North Run Capital's ten largest holdings make up 74% of its $789M portfolio in Q4 2013.
  • North Run Capital opened 4 new positions and closed 6 in Q4 2013.
  • North Run Capital's portfolio value rose 2.8% quarter-over-quarter to $789M.

Based on North Run Capital's 13F filing for Q4 2013, filed 14 Feb 2014.